Effect of induced hypertension with angiotensin II infusion on biodistribution of In-111-labeled monoclonal antibody

被引:11
作者
Kinuya, S
Yokoyama, K
Konishi, S
Tonami, N
Hisada, K
机构
[1] Department of Nuclear Medicine, Kanazawa Univ. School of Medicine, Kanazawa, Ishikawa 920
关键词
In-111-labeled monoclonal antibody; tumor targeting; induced hypertension; angiotensin II;
D O I
10.1016/0969-8051(95)02040-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We investigated whether induced hypertension could enhance tumor uptake of monoclonal antibody. In-111-DTPA-A7 (IgG, against 40kD tumor associated glycoprotein) was injected into colon carcinoma xenografted mice which were subcutaneously implanted with micro-osmotic pump containing angiotensin II (AT-II). Biodistribution was observed in groups of mice infused with AT-II at rate of 0.5 mu g/kg/min (L) or 1 mu g/kg/min (H) and compared with a group of mice infused with saline (S). Tumor uptake of In-111-A7 in L and H was 1.32 and 1.57 times greater than S at 48 h after intravenous injection of A7. Normal organ uptakes also tended to be increased by AT II infusion. Further study is needed to get optimum effect of hypertensive treatment on biodistribution of radiolabeled MoAb.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 23 条
  • [1] INCREASED INTRATUMOR CONCENTRATION OF FLUORESCEIN-ISOTHIOCYANATE-LABELED NEOCARZINOSTATIN IN RATS UNDER ANGIOTENSIN-INDUCED HYPERTENSION
    ABE, I
    HORI, K
    SAITO, S
    TANDA, S
    LI, YL
    SUZUKI, M
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1988, 79 (07): : 874 - 879
  • [2] BIODISTRIBUTIONS OF TL-201 IN TUMOR-BEARING ANIMALS AND INFLAMMATORY LESION INDUCED ANIMALS
    ANDO, A
    ANDO, I
    KATAYAMA, M
    SANADA, S
    HIRAKI, T
    MORI, H
    TONAMI, N
    HISADA, K
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1987, 12 (11): : 567 - 572
  • [3] BABA T, 1987, JPN J CANC CHEMOTHER, V14, P971
  • [4] THE RELATIONSHIP BETWEEN THALLIUM UPTAKE, BLOOD-FLOW, AND BLOOD POOL ACTIVITY IN BONE AND SOFT-TISSUE TUMORS
    CALUSER, C
    MACAPINLAC, H
    HEALEY, J
    GHAVIMI, F
    MEYERS, P
    WOLLNER, N
    KALAIGIAN, J
    KOSTAKOGLU, L
    ABDELDAYEM, HM
    YEH, SDJ
    LARSON, SM
    [J]. CLINICAL NUCLEAR MEDICINE, 1992, 17 (07) : 565 - 572
  • [5] DOUGLAS WW, 1980, PHARMACOL BASIS THER, P647
  • [6] GRIDLEY DS, 1990, CANCER RES, V50, P159
  • [7] EXPERIMENTAL-STUDY ON TUMOR AFFINITY OF TL-201-CHLORIDE
    ITO, Y
    MURANAKA, A
    HARADA, T
    MATSUDO, A
    YOKOBAYASHI, T
    TERASHIMA, H
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1978, 3 (02): : 81 - 86
  • [8] KALOFONOS H, 1990, CANCER RES, V50, P159
  • [9] LEBERTHON B, 1991, CANCER RES, V51, P2694
  • [10] MIYAUCHI T, 1994, J JUZEN MED SOC, V103, P453